Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HDL1
Term | Name | Level | Count |
---|---|---|---|
GO:0000413 | protein peptidyl-prolyl isomerization | 7 | 10 |
GO:0006807 | nitrogen compound metabolic process | 2 | 10 |
GO:0008152 | metabolic process | 1 | 10 |
GO:0018193 | peptidyl-amino acid modification | 5 | 10 |
GO:0018208 | peptidyl-proline modification | 6 | 10 |
GO:0019538 | protein metabolic process | 3 | 10 |
GO:0036211 | protein modification process | 4 | 10 |
GO:0043170 | macromolecule metabolic process | 3 | 10 |
GO:0043412 | macromolecule modification | 4 | 10 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 10 |
GO:0006457 | protein folding | 2 | 2 |
GO:0009987 | cellular process | 1 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 3 | 10 |
GO:0003824 | catalytic activity | 1 | 10 |
GO:0016853 | isomerase activity | 2 | 10 |
GO:0016859 | cis-trans isomerase activity | 3 | 10 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 10 |
GO:0005488 | binding | 1 | 1 |
GO:0016018 | cyclosporin A binding | 4 | 1 |
GO:0033218 | amide binding | 2 | 1 |
GO:0042277 | peptide binding | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 48 | 50 | PF00675 | 0.692 |
CLV_PCSK_KEX2_1 | 33 | 35 | PF00082 | 0.630 |
CLV_PCSK_PC1ET2_1 | 33 | 35 | PF00082 | 0.608 |
DOC_CYCLIN_yCln2_LP_2 | 14 | 20 | PF00134 | 0.447 |
DOC_MAPK_DCC_7 | 12 | 20 | PF00069 | 0.428 |
DOC_PP1_RVXF_1 | 10 | 17 | PF00149 | 0.428 |
DOC_PP1_RVXF_1 | 193 | 200 | PF00149 | 0.284 |
DOC_PP2B_LxvP_1 | 44 | 47 | PF13499 | 0.545 |
DOC_USP7_MATH_1 | 141 | 145 | PF00917 | 0.255 |
DOC_USP7_MATH_1 | 211 | 215 | PF00917 | 0.387 |
DOC_USP7_UBL2_3 | 112 | 116 | PF12436 | 0.290 |
DOC_USP7_UBL2_3 | 50 | 54 | PF12436 | 0.589 |
DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.434 |
DOC_WW_Pin1_4 | 90 | 95 | PF00397 | 0.340 |
LIG_14-3-3_CanoR_1 | 168 | 174 | PF00244 | 0.350 |
LIG_BRCT_BRCA1_1 | 12 | 16 | PF00533 | 0.431 |
LIG_BRCT_BRCA1_1 | 169 | 173 | PF00533 | 0.266 |
LIG_BRCT_BRCA1_1 | 175 | 179 | PF00533 | 0.252 |
LIG_Clathr_ClatBox_1 | 71 | 75 | PF01394 | 0.386 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.375 |
LIG_FHA_1 | 236 | 242 | PF00498 | 0.272 |
LIG_FHA_2 | 61 | 67 | PF00498 | 0.497 |
LIG_LIR_Gen_1 | 176 | 187 | PF02991 | 0.375 |
LIG_LIR_Gen_1 | 22 | 31 | PF02991 | 0.485 |
LIG_LIR_Gen_1 | 229 | 240 | PF02991 | 0.384 |
LIG_LIR_Nem_3 | 13 | 19 | PF02991 | 0.538 |
LIG_LIR_Nem_3 | 176 | 182 | PF02991 | 0.316 |
LIG_LIR_Nem_3 | 22 | 28 | PF02991 | 0.423 |
LIG_LIR_Nem_3 | 78 | 84 | PF02991 | 0.318 |
LIG_MLH1_MIPbox_1 | 175 | 179 | PF16413 | 0.260 |
LIG_PTB_Apo_2 | 119 | 126 | PF02174 | 0.375 |
LIG_SH2_CRK | 161 | 165 | PF00017 | 0.340 |
LIG_SH2_CRK | 81 | 85 | PF00017 | 0.375 |
LIG_SH2_STAT5 | 196 | 199 | PF00017 | 0.177 |
LIG_SUMO_SIM_par_1 | 82 | 87 | PF11976 | 0.340 |
LIG_UBA3_1 | 71 | 76 | PF00899 | 0.391 |
LIG_WW_3 | 46 | 50 | PF00397 | 0.626 |
MOD_CDK_SPK_2 | 90 | 95 | PF00069 | 0.340 |
MOD_CK1_1 | 107 | 113 | PF00069 | 0.185 |
MOD_CK1_1 | 169 | 175 | PF00069 | 0.381 |
MOD_CK1_1 | 26 | 32 | PF00069 | 0.683 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.689 |
MOD_CK1_1 | 90 | 96 | PF00069 | 0.423 |
MOD_CK2_1 | 26 | 32 | PF00069 | 0.683 |
MOD_GlcNHglycan | 169 | 172 | PF01048 | 0.255 |
MOD_GlcNHglycan | 185 | 188 | PF01048 | 0.237 |
MOD_GlcNHglycan | 218 | 222 | PF01048 | 0.435 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.484 |
MOD_GlcNHglycan | 89 | 92 | PF01048 | 0.329 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.385 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.321 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.433 |
MOD_N-GLC_1 | 107 | 112 | PF02516 | 0.321 |
MOD_NEK2_1 | 166 | 171 | PF00069 | 0.275 |
MOD_NEK2_1 | 173 | 178 | PF00069 | 0.282 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.476 |
MOD_NEK2_1 | 235 | 240 | PF00069 | 0.503 |
MOD_PIKK_1 | 173 | 179 | PF00454 | 0.319 |
MOD_PKA_2 | 126 | 132 | PF00069 | 0.316 |
MOD_PKA_2 | 167 | 173 | PF00069 | 0.307 |
MOD_PKA_2 | 183 | 189 | PF00069 | 0.265 |
MOD_Plk_1 | 235 | 241 | PF00069 | 0.411 |
MOD_Plk_4 | 10 | 16 | PF00069 | 0.541 |
MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.429 |
MOD_ProDKin_1 | 90 | 96 | PF00069 | 0.340 |
TRG_ENDOCYTIC_2 | 161 | 164 | PF00928 | 0.340 |
TRG_ENDOCYTIC_2 | 196 | 199 | PF00928 | 0.177 |
TRG_ENDOCYTIC_2 | 232 | 235 | PF00928 | 0.414 |
TRG_ENDOCYTIC_2 | 239 | 242 | PF00928 | 0.570 |
TRG_ENDOCYTIC_2 | 25 | 28 | PF00928 | 0.484 |
TRG_ENDOCYTIC_2 | 81 | 84 | PF00928 | 0.375 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3D1 | Leptomonas seymouri | 64% | 100% |
A0A1X0ND98 | Trypanosomatidae | 41% | 100% |
A0A1X0NJS0 | Trypanosomatidae | 27% | 100% |
A0A3S7WYD9 | Leishmania donovani | 80% | 100% |
A4I0X0 | Leishmania infantum | 80% | 100% |
C9ZT99 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 100% |
C9ZUX8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 80% |
C9ZWH7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 100% |
E9AWX4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 78% | 100% |
P30405 | Homo sapiens | 27% | 100% |
Q4QAK0 | Leishmania major | 79% | 100% |
V5B2A0 | Trypanosoma cruzi | 29% | 94% |
V5D532 | Trypanosoma cruzi | 27% | 100% |